Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.05
+7.32 (3.51%)
AAPL  263.95
+0.20 (0.08%)
AMD  197.23
+6.28 (3.29%)
BAC  50.05
+0.08 (0.16%)
GOOG  304.12
+0.56 (0.18%)
META  671.25
+16.17 (2.47%)
MSFT  404.44
+0.51 (0.13%)
NVDA  182.64
+2.59 (1.44%)
ORCL  151.84
+2.83 (1.90%)
TSLA  404.47
+12.04 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.